From Evaluation to Decision: A Practical Framework for Choosing the Right CDMO
August 12, 2026
Over the four posts in this series, we have built a complete framework for evaluating a CDMO for advanced therapy development. We...
Read more →Kate Broderick, PhD, Chief Scientific and Innovation Officer at Artis BioSolutions, joined a TechCon panel on what the next era of medicine will require. The conversation ranged...
Read More →August 12, 2026
Over the four posts in this series, we have built a complete framework for evaluating a CDMO for advanced therapy development. We...
Read more →